84095-08-9 Usage
Properties
1. Chemical Classification: Quaternary ammonium compound
2. Functional Groups:
Cyclopentylphenylacetyl moiety
Bromide anion
3. Structure:
Cyclic structure
Positively charged nitrogen atom (quaternary ammonium)
4. Synthesis: Synthetic organic compound
5. Usage: Pharmaceutical agent
6. Pharmacological Properties: Potentially beneficial for therapeutic applications
7. Applications:
Medicine
Therapeutic agent development
Moieties
Cyclopentylphenylacetyl: Contributes to the compound's structure and properties.
Hydroxy group: Adds polarity and potential for hydrogen bonding.
Functional Groups
Quaternary ammonium: Confers positive charge and potential for ionic interactions.
Bromide anion: Counter ion to balance the positive charge.
Structure
Bicyclic: Bicyclo[2.2.1]heptane core structure.
Positively Charged Nitrogen: Provides amphiphilic properties, potentially affecting interactions with biological systems.
Synthesis Type
Organic synthesis, likely involving multi-step reactions.
Usage
Pharmaceuticals: Potential therapeutic applications due to its pharmacological properties.
Potential Applications
Treatment of specific medical conditions: Due to its pharmaceutical nature, it may have applications in various therapeutic areas.
2-{[cyclopentyl(hydroxy)phenylacetyl]oxy}-7,7-dimethyl-7-azoniabicyclo[2.2.1]heptane bromide's unique combination of structure, functional groups, and pharmacological properties make it a promising candidate for further exploration in medicinal chemistry and drug development.
Check Digit Verification of cas no
The CAS Registry Mumber 84095-08-9 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 8,4,0,9 and 5 respectively; the second part has 2 digits, 0 and 8 respectively.
Calculate Digit Verification of CAS Registry Number 84095-08:
(7*8)+(6*4)+(5*0)+(4*9)+(3*5)+(2*0)+(1*8)=139
139 % 10 = 9
So 84095-08-9 is a valid CAS Registry Number.
84095-08-9Relevant academic research and scientific papers
7-azabicyclo [2.2. 1] heptane derivative bromide as well as preparation method and application thereof
-
Paragraph 0045-0070, (2021/04/21)
The invention belongs to the technical field of pharmaceutical compound crystal forms, and particularly relates to a 7-azabicyclo [2.2.1] heptane derivative bromide, and a preparation method and application thereof. The chemical name of the 7-azabicyclo [2.2.1] heptane derivative bromide provided by the invention is (1R,2S) -2- ((R) -2' -cyclopentyl-2 ' -hydroxy-2 ' -phenylacetoxy) -7, 7-dimethyl- 7-azabicyclo [2.2.1] heptane bromide, and X-ray powder diffraction has characteristic absorption peaks at 2 theta of 4.524 +/-0.2 degrees, 9.081 +/-0.2 degrees, 18.279 +/-0.2 degrees, 22.890 +/-0.2 degrees and 27.564 +/-0.2 degrees, and the bromide is powdery, is uniformly distributed and has good dispersibility.
7-AZONIABICYCLO [2.2.1] HEPTANE DERIVATIVES, METHODS OF PRODUCTION, AND PHARMACEUTICAL USES THEREOF
-
, (2011/08/21)
Muscarinic acetylcholine receptor antagonists and methods of using them for the treatment of muscarinic acetylcholine receptor-mediated diseases, such as pulmonary diseases, are provided.
Synthesis and bronchodilator activity of endo-2-(2-cyclopentyl-2-hydroxy-2-phenyl)acetoxy-7-methyl-7-azabicyclo-[2. 2.1]heptane methobromide, a potent and long-acting anticholinergic agent
Pfister,Wymann,Weissberg,Strossberg
, p. 208 - 210 (2007/10/02)
The synthesis of the α-cyclopentylmandelate ester of quaternized endo-7-methyl-7-azabicyclo[2.2.1]heptan-2-ol (4, RS-11635) is described. The key step of this synthesis consists of the intramolecular trans-diaxial epoxide opening of 4-(N-methylamino)-1,2-
